InvestorsHub Logo
Followers 13
Posts 842
Boards Moderated 0
Alias Born 01/29/2013

Re: None

Sunday, 10/14/2018 2:45:56 PM

Sunday, October 14, 2018 2:45:56 PM

Post# of 1318
I apologize to the board. I thought this ad com was a sure thing. I believed management when they implied the safety profile was superior to morphine and I did not expect the FDA to want tests at higher doses. I do believe O will be approved but only after a higher dose study. The only ACE this company has up its sleeve for the PDUFA meeting is that doctors want and need an alternative to the current standard of care. High Morphine doses. This may save their bacon. We'll see. But as many of the NO votes said... with some more data they would vote YES. As Hohger fans use to say...Maybe next year.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TRVN News